Xencor (XNCR) Interest & Investment Income (2013 - 2026)
Xencor (XNCR) posted quarterly Interest & Investment Income of $5.5 million for Q1 2026, down 27.58% year-over-year from $7.5 million in Q1 2025, and down 11.95% quarter-over-quarter from $6.2 million in Q4 2025.
Xencor (XNCR) Interest & Investment Income (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Interest & Investment Income for 10 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 27.58% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $25.4 million (down 17.71% YoY), while the FY2025 annual figure was $27.5 million, down 13.8% from the prior year.
- Interest & Investment Income slipped to $5.5 million in Q1 2026 per XNCR's latest filing, from $6.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $8.5 million in Q1 2024 and bottomed at $2.9 million in Q1 2023.
- Historically, Interest & Investment Income has averaged $6.8 million across 4 years, with a median of $7.4 million in 2024.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 194.86% — and 2026, when it retreated 27.58%.
- Xencor's Interest & Investment Income stood at $2.9 million in 2023, then surged by 181.61% to $8.2 million in 2024, then fell by 24.06% to $6.2 million in 2025, then slipped by 11.95% to $5.5 million in 2026.
- Business Quant data shows XNCR's Interest & Investment Income at $5.5 million in Q1 2026, $6.2 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - | 4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.80 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 8.16 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 7.68 Mn |
| Mar 31, 2024 | 8.55 Mn |
| Mar 31, 2023 | 2.90 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Sep 30, 2017 | 1.05 Mn |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 1.06 Mn |
| Dec 31, 2016 | 785,000.00 |
| Sep 30, 2016 | 579,000.00 |
| Jun 30, 2016 | 368,000.00 |